Anixa Biosciences, Inc. (ANIX): Price and Financial Metrics
ANIX Price/Volume Stats
| Current price | $3.34 | 52-week high | $4.20 |
| Prev. close | $3.60 | 52-week low | $2.07 |
| Day low | $3.30 | Volume | 168,500 |
| Day high | $3.59 | Avg. volume | 106,138 |
| 50-day MA | $2.75 | Dividend yield | N/A |
| 200-day MA | $2.96 | Market Cap | 107.58M |
ANIX Stock Price Chart Interactive Chart >
Anixa Biosciences, Inc. (ANIX) Company Bio
Anixa Biosciences, Inc., a biotechnology company, develops diagnostics and therapeutics to diagnose, treat, and prevent cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of cancer, which is based on the body's immune response to the presence of a malignancy. It is also developing a vaccine against triple negative breast cancer; and chimeric endocrine receptor T-cell technology focused on treating ovarian cancer. Anixa Biosciences, Inc. has a collaboration with Urology San Antonio, P.A. and Idaho Urologic Institute, PA for the development of Cchek, a liquid biopsy technology; and with OntoChem GmbH to develop novel Covid-19 therapeutics. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
ANIX Price Returns
| 1-mo | 32.54% |
| 3-mo | 12.84% |
| 6-mo | 19.29% |
| 1-year | 27.97% |
| 3-year | 5.36% |
| 5-year | 51.13% |
| YTD | 43.97% |
| 2024 | -40.21% |
| 2023 | -8.71% |
| 2022 | 43.10% |
| 2021 | -3.26% |
| 2020 | -6.40% |
Continue Researching ANIX
Here are a few links from around the web to help you further your research on Anixa Biosciences Inc's stock as an investment opportunity:Anixa Biosciences Inc (ANIX) Stock Price | Nasdaq
Anixa Biosciences Inc (ANIX) Stock Quote, History and News - Yahoo Finance
Anixa Biosciences Inc (ANIX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...